Skandinaviska Enskilda Banken AB publ purchased a new position in Chemed Corp. (NYSE:CHE) during the third quarter, Holdings Channel reports. The fund purchased 12,900 shares of the company’s stock, valued at approximately $1,820,000. Skandinaviska Enskilda Banken AB publ owned about 0.08% of Chemed Corp. as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of CHE. Capstone Asset Management Co. boosted its position in Chemed Corp. by 17.2% in the second quarter. Capstone Asset Management Co. now owns 2,480 shares of the company’s stock worth $338,000 after buying an additional 364 shares during the last quarter. Nordea Investment Management AB boosted its position in Chemed Corp. by 292.7% in the second quarter. Nordea Investment Management AB now owns 4,810 shares of the company’s stock worth $656,000 after buying an additional 3,585 shares during the last quarter. Parametrica Management Ltd acquired a new position in Chemed Corp. during the second quarter worth approximately $369,000. Smith Asset Management Group LP boosted its position in Chemed Corp. by 3.6% in the second quarter. Smith Asset Management Group LP now owns 23,229 shares of the company’s stock worth $3,166,000 after buying an additional 800 shares during the last quarter. Finally, Capital Fund Management S.A. boosted its position in Chemed Corp. by 8.6% in the second quarter. Capital Fund Management S.A. now owns 31,008 shares of the company’s stock worth $4,227,000 after buying an additional 2,455 shares during the last quarter. Institutional investors and hedge funds own 97.30% of the company’s stock.

Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)

Shares of Chemed Corp. (NYSE:CHE) traded up 0.57% during midday trading on Friday, reaching $166.23. 75,288 shares of the company’s stock traded hands. The firm has a market cap of $2.70 billion, a PE ratio of 26.53 and a beta of 1.23. Chemed Corp. has a 12 month low of $124.77 and a 12 month high of $166.62. The stock has a 50-day moving average price of $157.35 and a 200 day moving average price of $143.94.

Chemed Corp. (NYSE:CHE) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $1.73 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.82 by $0.09. Chemed Corp. had a return on equity of 23.95% and a net margin of 6.77%. The firm earned $392.61 million during the quarter, compared to the consensus estimate of $270.44 million. During the same period in the previous year, the company posted $1.78 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. Equities research analysts predict that Chemed Corp. will post $7.24 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Skandinaviska Enskilda Banken AB publ Takes Position in Chemed Corp. (CHE)” was originally reported by Daily Political and is the propert of of Daily Political. If you are accessing this news story on another site, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The correct version of this news story can be read at http://www.dailypolitical.com/2017/01/13/skandinaviska-enskilda-banken-ab-publ-takes-position-in-chemed-corp-che.html.

A number of equities analysts recently commented on CHE shares. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $155.00 price target on shares of Chemed Corp. in a report on Tuesday, September 27th. Royal Bank Of Canada reduced their price target on Chemed Corp. from $162.00 to $148.00 and set a “sector perform” rating for the company in a report on Tuesday, November 1st. RBC Capital Markets reiterated a “sector perform” rating and set a $148.00 price target (down previously from $162.00) on shares of Chemed Corp. in a report on Tuesday, November 1st. Finally, Zacks Investment Research cut Chemed Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, November 1st. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $154.50.

In other Chemed Corp. news, Director Patrick P. Grace sold 400 shares of the company’s stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $148.53, for a total value of $59,412.00. Following the completion of the sale, the director now directly owns 4,597 shares of the company’s stock, valued at approximately $682,792.41. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Spencer S. Lee sold 4,500 shares of the company’s stock in a transaction dated Monday, November 14th. The stock was sold at an average price of $150.22, for a total transaction of $675,990.00. Following the completion of the sale, the insider now directly owns 35,367 shares of the company’s stock, valued at $5,312,830.74. The disclosure for this sale can be found here. 5.32% of the stock is currently owned by company insiders.

About Chemed Corp.

Chemed Corporation operates and divests subsidiaries engaged in diverse business activities. The Company operates its business in two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

5 Day Chart for NYSE:CHE

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.